Lithium does not attenuate the effects of d-amphetamine in healthy volunteers

[1]  P. Silverstone,et al.  Diltiazem, a calcium antagonist, partly attenuates the effects of dextroamphetamine in healthy volunteers , 1997, International clinical psychopharmacology.

[2]  L. Brauer,et al.  High Dose Pimozide Does Not Block Amphetamine-Induced Euphoria in Normal Volunteers , 1997, Pharmacology Biochemistry and Behavior.

[3]  M. Schou.  Forty years of lithium treatment. , 1997, Archives of general psychiatry.

[4]  W. H. Barr,et al.  Comparison of Methods for the Assessment of Central Nervous System Stimulant Response after Dextroamphetamine Administration to Healthy Male Volunteers , 1996, Journal of clinical pharmacology.

[5]  D. Murphy,et al.  Biological and behavioral responses to d-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers , 1996, Psychiatry Research.

[6]  E. Floor,et al.  Amphetamine releases dopamine from synaptic vesicles by dual mechanisms , 1996, Neuroscience Letters.

[7]  L. Brauer,et al.  Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers , 1996, Biological Psychiatry.

[8]  Martin D. Bootman,et al.  The elemental principles of calcium signaling , 1995, Cell.

[9]  H. Manji,et al.  Signal transduction pathways. Molecular targets for lithium's actions. , 1995, Archives of general psychiatry.

[10]  G. Hamdan-Allen,et al.  Case study: antimanic effectiveness of dextroamphetamine in a brain-injured adolescent. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  R. Wyatt,et al.  The Na,K-ATPase hypothesis for bipolar illness , 1995, Biological Psychiatry.

[12]  G. Koob,et al.  Dopamine receptor agonists, partial agonists and psychostimulant addiction. , 1994, Trends in pharmacological sciences.

[13]  H. Manji,et al.  Long‐term action of lithium: A role for transcriptional and posttranscriptional factors regulated by protein kinase C , 1994, Synapse.

[14]  L S Seiden,et al.  Amphetamine: effects on catecholamine systems and behavior. , 1993, Annual review of pharmacology and toxicology.

[15]  G. Chiara,et al.  Endogenous Dopamine Facilitates Striatalln Vivo Acetylcholine Release by Acting on D1 Receptors Localized in the Striatum , 1992, Journal of neurochemistry.

[16]  M. Rapport,et al.  The effects of methylphenidate and lithium on attention and activity level. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  B. Agranoff,et al.  Inositol Lipids and Signal Transduction in the Nervous System: An Update , 1992, Journal of neurochemistry.

[18]  H. de Wit,et al.  Effects of setting on the subjective and behavioral effects of d-amphetamine in humans. , 1992, Addictive behaviors.

[19]  R. Foltin,et al.  Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. , 1991, British journal of addiction.

[20]  P. Cappeliez,et al.  Effects of lithium on an amphetamine animal model of bipolar disorder , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  F. Goodwin.  Manic-Depressive Illness , 1990 .

[22]  A. Altamura,et al.  Alternative Prophylactic Treatments to Lithium in Bipolar Disorders , 1990, Clinical neuropharmacology.

[23]  B. Hoebel,et al.  Microdialysis Studies of Brain Norepinephrine, Serotonin, and Dopamine Release During Ingestive Behavior Theoretical and Clinical Implications a , 1989, Annals of the New York Academy of Sciences.

[24]  Michael J. Berridge,et al.  Inositol phosphates and cell signalling , 1989, Nature.

[25]  S. Snyder,et al.  Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium. , 1989, The American journal of psychiatry.

[26]  June Corwin,et al.  Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects , 1987, Biological Psychiatry.

[27]  M. Garvey,et al.  Dextroamphetamine treatment of mania. , 1987, The Journal of clinical psychiatry.

[28]  G. Goodwin,et al.  A review of the biochemical and neuropharmacological actions of lithium , 1987, Psychological Medicine.

[29]  George W.Arana,et al.  Handbook of psychiatric drug therapy , 1987 .

[30]  T. Silverstone,et al.  Dextroamphetamine-induced arousal in human subjects as a model for mania , 1986, Psychological Medicine.

[31]  D J Kupfer,et al.  Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. , 1984, Archives of general psychiatry.

[32]  R. Hamer,et al.  The neuroendocrine and behavioral response to dextroamphetamine in normal individuals. , 1984, Biological psychiatry.

[33]  T. Silverstone,et al.  The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man , 1980, Neuropharmacology.

[34]  B. Angrist,et al.  Variable attenuation of amphetamine effects by lithium. , 1979, The American journal of psychiatry.

[35]  W. Brown,et al.  Alleviation of manic symptoms with catecholamine agonists. , 1979, The American journal of psychiatry.

[36]  J. Tecce,et al.  Amphetamine Effects in Man: Paradoxical Drowsiness and Lowered Electrical Brain Activity (CNV) , 1974, Science.

[37]  A. Flemenbaum.  Does lithium block the effects of amphetamine? A report of three cases. , 1974, The American journal of psychiatry.

[38]  H. M. V. Praag.  Psychiatria, neurologia, neurochirurgia , 1973 .

[39]  E. Anggard,et al.  Clinical trials with amphetamine-blocking drugs. , 1972, Psychiatria, neurologia, neurochirurgia.